Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Astera Labs (ALAB)

Astera Labs adds Craig Barratt to board, expands it to eight directors

Neutral Impact 2 of 5 leadership Written later

Astera Labs increased its board from seven to eight members and appointed Dr. Craig Barratt as a director effective March 2, 2025. He also replaced Manuel Alba on the Audit Committee, and the board classed him as independent. The filing describes a routine board addition with a standard director compensation package.

Key points

  • Craig Barratt appointed to the Board effective March 2, 2025; board increased from seven to eight directors
  • Replaces Manuel Alba on the Audit Committee; Barratt designated a Class II director, expected to stand for election at the 2026 Annual Meeting
  • Compensation: $60,000 annual Board retainer, $12,500 annual Audit Committee retainer (prorated for 2025), and a one-time RSU award with a fair market value of $330,000 vesting in equal annual installments over three years

The filing

CompanyAstera Labs (ALAB)
Form8-K, current report
Filed with the SECMar 3, 2025, 4:15 PM ET
Accession number0001736297-25-000018

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:30 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 03, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.